Vanguard Group’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $112M | Buy |
2,298,089
+528,380
| +30% | +$25.7M | ﹤0.01% | 1788 |
|
|
2025
Q1 | $60.2M | Buy |
1,769,709
+33,711
| +2% | +$1.15M | ﹤0.01% | 2017 |
|
|
2024
Q4 | $68.3M | Buy |
1,735,998
+10,579
| +0.6% | +$416K | ﹤0.01% | 2029 |
|
|
2024
Q3 | $81.1M | Sell |
1,725,419
-23,094
| -1% | -$1.08M | ﹤0.01% | 1973 |
|
|
2024
Q2 | $94.4M | Buy |
1,748,513
+111,714
| +7% | +$6.03M | ﹤0.01% | 1858 |
|
|
2024
Q1 | $112M | Buy |
1,636,799
+46,148
| +3% | +$3.15M | ﹤0.01% | 1807 |
|
|
2023
Q4 | $99.6M | Buy |
1,590,651
+51,926
| +3% | +$3.25M | ﹤0.01% | 1865 |
|
|
2023
Q3 | $69.8M | Buy |
1,538,725
+7,635
| +0.5% | +$347K | ﹤0.01% | 1978 |
|
|
2023
Q2 | $86M | Buy |
1,531,090
+46,521
| +3% | +$2.61M | ﹤0.01% | 1934 |
|
|
2023
Q1 | $67.1M | Buy |
1,484,569
+42,292
| +3% | +$1.91M | ﹤0.01% | 2031 |
|
|
2022
Q4 | $58.6M | Buy |
1,442,277
+6,867
| +0.5% | +$279K | ﹤0.01% | 2105 |
|
|
2022
Q3 | $93.8M | Buy |
1,435,410
+112,269
| +8% | +$7.34M | ﹤0.01% | 1825 |
|
|
2022
Q2 | $80.4M | Buy |
1,323,141
+105,852
| +9% | +$6.43M | ﹤0.01% | 1946 |
|
|
2022
Q1 | $76.4M | Buy |
1,217,289
+880,463
| +261% | +$55.3M | ﹤0.01% | 2086 |
|
|
2021
Q4 | $25.5M | Sell |
336,826
-23,715
| -7% | -$1.8M | ﹤0.01% | 2710 |
|
|
2021
Q3 | $40.4M | Buy |
360,541
+96,783
| +37% | +$10.8M | ﹤0.01% | 2480 |
|
|
2021
Q2 | $42.7M | Buy |
263,758
+4,061
| +2% | +$657K | ﹤0.01% | 2455 |
|
|
2021
Q1 | $31.6M | Buy |
259,697
+9,557
| +4% | +$1.16M | ﹤0.01% | 2562 |
|
|
2020
Q4 | $38.3M | Sell |
250,140
-140,284
| -36% | -$21.5M | ﹤0.01% | 2338 |
|
|
2020
Q3 | $32.7M | Buy |
390,424
+56,870
| +17% | +$4.76M | ﹤0.01% | 2234 |
|
|
2020
Q2 | $24.5M | Buy |
333,554
+147,782
| +80% | +$10.9M | ﹤0.01% | 2323 |
|
|
2020
Q1 | $7.88M | Buy |
185,772
+15,637
| +9% | +$663K | ﹤0.01% | 2727 |
|
|
2019
Q4 | $10.4M | Buy |
170,135
+88,044
| +107% | +$5.36M | ﹤0.01% | 2842 |
|
|
2019
Q3 | $3.37M | Buy |
82,091
+932
| +1% | +$38.2K | ﹤0.01% | 3276 |
|
|
2019
Q2 | $3.82M | Buy |
81,159
+16,821
| +26% | +$792K | ﹤0.01% | 3262 |
|
|
2019
Q1 | $2.3M | Buy |
64,338
+4,283
| +7% | +$153K | ﹤0.01% | 3400 |
|
|
2018
Q4 | $1.72M | Buy |
60,055
+8,032
| +15% | +$230K | ﹤0.01% | 3420 |
|
|
2018
Q3 | $2.31M | Buy |
52,023
+3,200
| +7% | +$142K | ﹤0.01% | 3478 |
|
|
2018
Q2 | $2.87M | Buy |
48,823
+7,479
| +18% | +$439K | ﹤0.01% | 3392 |
|
|
2018
Q1 | $1.89M | Buy |
41,344
+24,076
| +139% | +$1.1M | ﹤0.01% | 3474 |
|
|
2017
Q4 | $405K | Sell |
17,268
-15
| -0.1% | -$352 | ﹤0.01% | 3795 |
|
|
2017
Q3 | $309K | Buy |
17,283
+264
| +2% | +$4.72K | ﹤0.01% | 3837 |
|
|
2017
Q2 | $273K | Buy |
+17,019
| New | +$273K | ﹤0.01% | 3846 |
|